decisional tools to determine need for biopsy and re-biopsy in men with elevated psas
Published 2 years ago • 772 plays • Length 18:21Download video MP4
Download video MP3
Similar videos
-
12:50
imaging tools for improving risk assessment and patient selection for biopsy
-
17:40
when to biopsy: the role for psa and novel biomarkers
-
21:09
an overview of mri guided biopsies for prostate cancer
-
40:22
biomarkers: psa, 4k, or phi?
-
4:28
ask the expert: what are the options in treating persistently elevated psa and negative biopsy?
-
11:54
screening and prevention of prostate cancer 2021 - who needs a biopsy?
-
6:18
updates of changes in the early detection of prostate cancer nccn guidelines 2021
-
16:36
early diagnosis of prostate cancer: a path forward
-
20:00
mri/us fusion biopsy
-
25:24
active surveillance in 2021 part 2: imaging and biomarkers
-
13:28
pathologist's perspective on biopsy results: transperineal mapping vs. fusion biopsy
-
13:25
progess in understanding pathology of prostate cancer
-
26:42
transperineal mapping biopsy defines tumor type and location
-
14:38
elevated psa & mri targeted biopsy - prostate cancer webinar with dr. jim hu
-
10:07
nccn guidelines for early detection of prostate cancer 2023
-
16:24
patient selection for focal therapy: what is an optimal biopsy strategy?
-
7:08
updates in screening: prostate cancer guidelines
-
10:37
liquid diagnostics and prostate cancer
-
3:22
transperineal biopsy